Gsk Share Discussion Threads

[fangorn2] 30/8/2018 11:26

Super news...

"GSK's treatment for children with severe asthma receives EU approval"


Have to feel for Astra Zeneca though...
Positive news on T2 diabetes device offset by:

"The U.S. Food and Drug Administration said on Wednesday a serious genital infection has been reported in patients taking SGLT2 inhibitors, a certain class of diabetes drugs approved for AstraZeneca Plc and
several other firms."

Yikes!

[abdullla] 30/8/2018 10:24

Yes I am collecting filters!

[doohoma3] 30/8/2018 09:29

Abdul here as well when is he going to e u a site

[tradermichael] 30/8/2018 08:50

RTTNews) - GlaxoSmithKline (GSK, GSK.L) announced that the European Commission has granted marketing authorisation for Nucala (mepolizumab) as an add-on treatment for severe refractory eosinophilic asthma in paediatric patients aged six up to 17 years. As a result of the licence extension Nucala is now approved for use for severe refractory eosinophilic asthma in both adult and paediatric patients in the 31 European countries covered by the European Medicines Agency.
Nucala is the first and only approved biologic therapy for paediatric patients with severe asthma that targets interleukin-5, which plays an important role in regulating the function of eosinophils.

[abdullla] 30/8/2018 08:43

Good timing

[tradermichael] 30/8/2018 08:13

IN ... 3489 shares @ 1584.178p

[alphorn] 29/8/2018 11:36

rikky - posted something on my thread - IMO it could move sharply either way in sterling terms. (Remain long at present).

[rikky72] 29/8/2018 11:35

Could see this treading water around the £16 mark for the next few months. Any other views, whether bullish or bearish?

[tradermichael] 28/8/2018 08:04

thecashmoney
27 Aug '18 - 18:11 - 18028 of 18028 (Filtered)

[thecashmoney] 27/8/2018 18:11

Check nuog ,well worth a look if you're looking for growth from low cap ,deal expected shortly .

[thecashmoney] 27/8/2018 18:10

Just do your own research and ignore the noise is my advice,it's quite obvious that NUOG /MFDEVCO is on the cusp of transformational news .Comms from the company via tweets says negotiations are drawing to a conclusion,last rns from chairman states it's progressing .Recent podcast designed to be non promotional imvho .Think of it like buying a car ,you don't tell the other parties how much you love it ,you say it needs new tyres , exhaust is on its way out etc ,you want the best deal possible . According to my research it's a win win win for all involved. OSX-3 owners want more from their asset , dommo current operators need cash revenue to raise to develop other assets.Mfdevco obviously will be truly transformational as the podcast states it will put mfdevco in a very forward position,with most of the steps allready completed,alot of money has already been spent and will put this company in a very advanced state compared to its current market capitalisation.CM

[richard xii] 25/8/2018 02:57

The new Barron's agrees with you TraderMichael. They think Shingrix could generate $2 billion annual sales by 2022.Quote:Shares of Glaxo have returned 21%, 13 percentage points more than the S&P 500 index, since we recommended them late last year.They still look cheap at 14 times this year's projected earnings. Investors have begun to recognize the company's new growth drivers, but still don't give it credit for its pipeline of products in development, according to UBS analyst Michael Leuchten. For shareholders, there's no hurry to sell.

[tradermichael] 24/8/2018 15:28

Yes, they are putting a 1790p price on it.

Additionally, I think the potential for Shingrix has not been fully appreciated as well …. ;0)

[abdullla] 24/8/2018 14:00

Berenberg Says Glaxo HIV Drug Cabotegravir Is UnderratedBerenberg reiterated its Buy rating on GlaxoSmithKline saying the drugmaker's Cabotegravir treatment has been under-appreciated by the market...

[abdullla] 24/8/2018 13:40

As James bond says, "she has had her kicks"

[tradermichael] 24/8/2018 13:31

Sold too soon, don't you think?

My 36,883 shares are a HOLD …… ;0)

[abdullla] 24/8/2018 13:20

DIRECTOR DEALINGS: Glaxo Senior Executive Sells GBP481,000 In SharesSource: Alliance NewsGlaxoSmithKline PLC said Friday that Senior Vice President for human resources Claire Thomas sold 30,000 shares in the company. Thomas sold

[tradermichael] 24/8/2018 07:18

Dr B - The Republican healthcare plan has been unable to pass the Senate, and has been mauled by doctors' groups, hospitals and other parts of the medical industry, mainly because of its deep cuts to Medicaid, the health programme for the poor, and fears that millions would lose insurance.

[tim 3] 23/8/2018 23:18

Without wanting to bring the Brexit debate onto yet another thread I think you are right this looks increasingly likely to be anything but smooth.

[dr biotech] 23/8/2018 14:27

Trump claims a lot of things, with very little evidence. Impeachment wouldn't be a positive due to uncertainty but I think the US is overpriced and heading for a fall when there is a realisation that the tarrifs are hurting and the tax cut is widening the deficit.

But amongst his many lies the most specific to GSK was his claim that he would repeal and replace Obamacare with something cheaper and better from day1. It will be interesting to see what he will do though if he sets his targets on that.

[tradermichael] 23/8/2018 14:03

Donald Trump claims markets will "crash" if he is impeached over alleged wrongdoing in the 2016 election campaign. 

[blueteam] 23/8/2018 08:37

yes Horlicks sale will see the £17 broken, then will need to push on.